Anicom Holdings (8715) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Jul, 2026Executive summary
Recurring revenue rose 10.6% year-over-year to JPY 54,995 million, driven by growth in pet insurance, new policy acquisition, and expansion of peripheral businesses.
Recurring profit declined 41.2% year-over-year to JPY 2,228 million due to higher underwriting and administrative expenses, costs from AXA Direct policy transfers, and business investments.
Net profit dropped 44.6% year-over-year to JPY 1,426 million.
The number of policies in force increased by 86,307 (6.7%) from the previous fiscal year-end, reaching 1,374,230.
The company expanded its health innovation and veterinary clinic management businesses alongside core pet insurance operations.
Financial highlights
Underwriting revenue increased 9.8% year-over-year to JPY 47,747 million; investment revenue surged 47.6% to JPY 1,190 million.
Other recurring revenue grew 12.3% to JPY 6,056 million.
Underwriting expenses increased 12.1% to JPY 34,623 million, and operating/general administrative expenses rose 21.3% to JPY 15,767 million.
Basic earnings per share for the period was JPY 19.23, down from JPY 33.02 in the prior year.
Total assets as of December 31, 2025, were JPY 73,478 million, with net assets at JPY 28,339 million and an equity ratio of 38.8%.
Outlook and guidance
Full-year recurring revenue is forecast at JPY 73,000 million (up 7.9% year-over-year), with recurring profit projected at JPY 3,300 million (down 13.4%).
Profit attributable to owners of parent is expected to be JPY 2,100 million (down 35.3%), with basic EPS of JPY 28.45.
Dividend forecast for the year ending March 31, 2026, is JPY 9.00 per share.
Cost reductions and improved asset management income are expected to offset the absence of one-time transfer fees in 4Q.
Latest events from Anicom Holdings
- Double-digit profit and revenue growth driven by new policies and strong pet insurance demand.8715
Q3 202513 Jul 2026 - Record-high revenue and profit driven by pet insurance growth and investment gains, with lower profit forecasted.8715
Q4 202513 Jul 2026 - Revenue up 10.4% YoY, but profit down over 40% amid higher expenses and policy transfer costs.8715
Q1 202613 Jul 2026 - Recurring revenue and profit surged on strong pet insurance demand and operational efficiency.8715
Q1 202513 Jul 2026 - Double-digit recurring revenue and profit growth driven by robust pet insurance demand.8715
Q2 202513 Jul 2026 - Recurring revenue up 10.6% YoY, but profit down 34.4% amid higher expenses and loss ratios.8715
Q2 202613 Jul 2026 - Recurring revenue up 9.1%, profit down 32.1%, with strong FY03/27 growth and higher dividends forecast.8715
Q4 202613 Jul 2026